Boehringer Ingelheim Commits to Veeva Vault CRM
Top biopharma company selects the next generation of CRM for life sciences as its commercial foundation for future expansion and launches ...
With $66 million R&D center, Boehringer Ingelheim fulfills economic development pledge to state
The $66 million project is part of the company's obligation made to the state after it moved here to invest a total of $120 ...
FierceBiotech14d
Boehringer Ingelheim drops obesity drug from Gubra partnership
Boehringer Ingelheim has halted development of an obesity drug from Gubra that it originally pledged to advance back in 2017, ...
pharmaphorum1d
Boehringer bags first approval for rare skin disease drug
German drugmaker Boehringer Ingelheim has its first regulatory approval ... The FDA has cleared the IL-36 receptor inhibitor under the Spevigo brand name to treat the devastating eruptions of ...
German pharmaceutical company sees great benefits from CIIE's spillover effect
STORY German pharmaceutical company sees great benefits from CIIE spillover effectSHOOTING TIME Recent footageDATELINE Nov 10 2024LENGTH 00011 ...
The Pharma Letter10d
Boehringer mental health tie-up worth up to $126.5 million to Broad Institute
Privately-held German drugmaker Boehringer Ingelheim and researchers from the Stanley Center for Psychiatric Research at the ...
‘Sick day’ on the clock: CT Biopharma firm expands patient simulations to spark creativity, empathy
Spending the day facing the challenges of kidney patients helps workers at a CT pharmaceutical company understand disease and ...
pharmaphorum6d
Boehringer says R&D pipeline is the best in its long history
Boehringer Ingelheim says it is on track to launch ... The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement ...
Boehringer Ingelheim Limited: Boehringer Ingelheim and the Mary Tyler Moore Vision Initiative join forces to combat vision loss from diabetes
More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the leading cause of blindness in working-age adults. 1·DRD is a growing epidemic ...
Finanznachrichten3h
Veeva Systems: Boehringer Ingelheim Commits to Veeva Vault CRM
Boehringer Ingelheim is seeking to expand on its existing Veeva Commercial ... Veeva Forward-looking Statements This release contains forward-looking statements regarding Veeva's products and services ...